Petros Sountoulides

Patient’s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?

Luca Cindolo, Luisella Pirozzi, Petros Sountoulides et al. · BMC Urology · 2015 · 78 citations · Full text

Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1–pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors?

Sabine Brookman‐May, Matthias May, Ingmar Wolff et al. · European Urology · 2015 · 54 citations · Full text

Stage Pt3a Tumors, Prognostic Biomarkers, Urology +9

Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer: Prevention and Management

Petros Sountoulides, T. Rountos · ISRN Urology · 2013 · 53 citations · Full text

Hormonal Contraceptive, Urology, Genitourinary Cancer +12

Secondary malignancies following radiotherapy for prostate cancer

Petros Sountoulides, Nikolaos Koletsas, D. Kikidakis et al. · Therapeutic Advances in Urology · 2010 · 53 citations · Full text

Urology, Radiation Medicine, Diagnostic Modalities +12

Anatomical variation of left internal jugular vein

Irene Asouhidou, Konstantinos Natsis, Th. Asteri et al. · European Journal of Anaesthesiology · 2008 · 38 citations